Ratings changes for NVIDIA, Chord Energy, Workday, Sportradar Group, PTC Therapeutics, Texas Roadhouse, Zscaler and more...Upgrade to MarketBeat All Access to get our best stock ideas, proprietary research, portfolio monitoring tools, and more. Start Your Free Trial.

May 27th, 2026

Here's the BIG PROBLEM with the SpaceX IPO (Ad)

SpaceX's IPO filing is now public, with a valuation nearing $1.5 trillion - but hedge funds, Goldman partners, and underwriting banks are already scooping up pre-IPO shares where, according to a recent study, 95% of the gains are made.
Dr. Mark Skousen, a 77-year-old macroeconomic strategist, says he's found a 'backdoor' way for regular Americans to position themselves before the public offering. He's already helped nearly 15,000 investors learn this approach and says June is the window to watch.
Get his free SpaceX pre-IPO recommendation - no credit card required.

Claim your free SpaceX pre-IPO recommendation before the June window closes

Today's Top Stories

3 Stocks Under $40 with Indirect Exposure to SpaceX IPO

By Chris Markoch | May 27, 2026 10:55 AM

Buy This: 50 Times More Upside than SpaceX? (Ad)

By Brownstone Research

Record Revenue, Rising Dividends—So Why Aren't Analysts Saying Buy?

By Peter Frank | May 27, 2026 10:55 AM

Rocket Lab Keeps Making Headlines and Highs—Here's What's Driving the Latest Move

By Ryan Hasson | May 27, 2026 09:45 AM

Before SpaceX goes public, watch this tiny supplier closely (Ad)

By Weiss Ratings

Micron’s $1 Trillion Memory Melt-Up

By Jeffrey Neal Johnson | May 27, 2026 09:05 AM

Quantum Computing's Commercial Breakout Has Arrived

By Jeffrey Neal Johnson | May 27, 2026 08:35 AM

Quick Links

Analyst Ratings My MarketBeat Account Settings MarketBeat All Access Stock Lists Stock Screener Calculators Premium Reports Best Stocks to Buy in May

The NASTY TRUTH about the SpaceX IPO (Ad)

In nearly every major IPO, roughly 95% of the gains are captured before retail investors can place a trade. It happened with Facebook, Uber, and Airbnb - hedge funds and underwriting banks buy in cheap, then help set the public opening price.
Dr. Mark Skousen, Macroeconomic Strategist at The Oxford Club, says he has identified a backdoor that lets regular Americans take a pre-IPO position in SpaceX right now. Nearly 15,000 readers have already accessed the details.

Click here to see how the SpaceX backdoor works before June

Analysts' Upgrades

Advanced Drainage Systems (NYSE:WMS) was upgraded by Stephens from "equal weight" to "overweight". They now have a $175.00 price target on the stock. This represents a 24.8% upside from the current price of $140.18.

BBB Foods (NYSE:TBBB) was upgraded by HSBC Holdings plc from "hold" to "buy". They now have a $47.00 price target on the stock. This represents a 32.8% upside from the current price of $35.40.

CDW (NASDAQ:CDW) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $130.00 price target on the stock. This represents a 13.7% upside from the current price of $114.33.

Digital Turbine (NASDAQ:APPS) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $7.50 price target on the stock. This represents a 0.7% upside from the current price of $7.45.

Equity Residential (NYSE:EQR) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $76.00 price target on the stock. This represents a 13.0% upside from the current price of $67.24.

FedEx (NYSE:FDX) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $460.00 price target on the stock, up from $432.00. This represents a 11.6% upside from the current price of $412.29.

H. B. Fuller (NYSE:FUL) was upgraded by JPMorgan Chase & Co. from "underweight" to "neutral". They now have a $58.00 price target on the stock. This represents a 6.7% downside from the current price of $62.15.

ICU Medical (NASDAQ:ICUI) was upgraded by Needham & Company LLC from "hold" to "buy". They now have a $165.00 price target on the stock. This represents a 18.9% upside from the current price of $138.79.

Ingram Micro (NYSE:INGM) was upgraded by JPMorgan Chase & Co. from "underweight" to "neutral". They now have a $27.00 price target on the stock. This represents a 1.5% downside from the current price of $27.41.

Insight Enterprises (NASDAQ:NSIT) was upgraded by JPMorgan Chase & Co. from "underweight" to "neutral". They now have a $105.00 price target on the stock. This represents a 1.3% upside from the current price of $103.68.

MGM Resorts International (NYSE:MGM) was upgraded by Truist Financial Corporation from "hold" to "buy". They now have a $55.00 price target on the stock. This represents a 29.5% upside from the current price of $42.46.

MGM Resorts International (NYSE:MGM) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $46.00 price target on the stock. This represents a 8.3% upside from the current price of $42.46.

Openlane (NYSE:OPLN) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $38.00 price target on the stock, up from $33.00. This represents a 3.3% upside from the current price of $36.79.

Pebblebrook Hotel Trust (NYSE:PEB) was upgraded by Truist Financial Corporation from "hold" to "buy". They now have a $17.00 price target on the stock. This represents a 10.0% upside from the current price of $15.46.

PTC Therapeutics (NASDAQ:PTCT) was upgraded by Jefferies Financial Group Inc. from "hold" to "buy". They now have a $85.00 price target on the stock. This represents a 20.5% upside from the current price of $70.53.

TD SYNNEX (NYSE:SNX) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $298.00 price target on the stock. This represents a 21.1% upside from the current price of $245.99.

View More Upgrades

Why 67 years of computer chip making just ended (Ad)

For 67 years, chip-making meant slicing a single silicon wafer into hundreds of pieces. Three companies just abandoned that model entirely, building one giant solid super-chip the size of a dinner plate that already crunches more data in minutes than today's top AI systems handle in days.
Tech forecaster George Gilder - who called the iPhone, Netflix, and Amazon early - believes this technology could make today's AI giants the next BlackBerry. He's identified three specific companies he calls the Trillion Dollar Triangle.

See the three companies George Gilder is calling the Trillion Dollar Triangle

Analysts' Downgrades

ACNB (NASDAQ:ACNB) was downgraded by Hovde Group from "outperform" to "market perform". They now have a $57.00 price target on the stock, up from $56.00. This represents a 4.5% upside from the current price of $54.54.

Quantasing Group (NASDAQ:HERE) was downgraded by Citigroup Inc. from "buy" to "neutral". They now have a $2.50 price target on the stock. This represents a 13.1% upside from the current price of $2.21.

Ralliant (NYSE:RAL) was downgraded by Vertical Research from "buy" to "hold". They now have a $65.00 price target on the stock. This represents a 4.1% upside from the current price of $62.42.

Sportradar Group (NASDAQ:SRAD) was downgraded by JPMorgan Chase & Co. from "overweight" to "neutral". They now have a $16.00 price target on the stock. This represents a 23.5% upside from the current price of $12.96.

Verra Mobility (NASDAQ:VRRM) was downgraded by CJS Securities from "market outperform" to "market perform". They now have a $10.00 price target on the stock. This represents a 164.9% upside from the current price of $3.78.

Winnebago Industries (NYSE:WGO) was downgraded by Citigroup Inc. from "buy" to "neutral". They now have a $30.00 price target on the stock. This represents a 0.2% downside from the current price of $30.05.

Xiaomi (OTCMKTS:XIACF) was downgraded by Jefferies Financial Group Inc. from "hold" to "underperform". The current price is $3.69.

View More Downgrades

Read this or regret it forever (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift:
“Don’t Say I Didn’t Warn You”
Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.

Don’t be left behind. Click here now.

Analysts' New Coverage

Agilent Technologies (NYSE:A) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $153.00 price target on the stock. This represents a 32.8% upside from the current price of $115.22.

Athira Pharma (NASDAQ:LONA) is now covered by Piper Sandler. They set an "overweight" rating and a $20.00 price target on the stock. This represents a 99.1% upside from the current price of $10.05.

Booz Allen Hamilton (NYSE:BAH) is now covered by BNP Paribas Exane. They set a "neutral" rating and a $80.00 price target on the stock. This represents a 0.5% downside from the current price of $80.44.

CACI International (NYSE:CACI) is now covered by BNP Paribas Exane. They set a "neutral" rating and a $550.00 price target on the stock. This represents a 7.8% upside from the current price of $510.16.

Cellebrite DI (NASDAQ:CLBT) is now covered by DA Davidson. They set a "buy" rating and a $20.00 price target on the stock. This represents a 56.5% upside from the current price of $12.78.

Century Therapeutics (NASDAQ:IPSC) is now covered by Mizuho. They set an "outperform" rating and a $8.00 price target on the stock. This represents a 232.6% upside from the current price of $2.41.

Dave (NASDAQ:DAVE) is now covered by Evercore Inc. They set an "in-line" rating and a $260.00 price target on the stock. This represents a 2.5% upside from the current price of $253.60.

Genmab A/S (NASDAQ:GMAB) is now covered by Truist Financial Corporation. They set a "buy" rating and a $40.00 price target on the stock. This represents a 49.6% upside from the current price of $26.74.

Intuit (NASDAQ:INTU) is now covered by Bank of America Corporation. They set a "buy" rating and a $400.00 price target on the stock. This represents a 28.6% upside from the current price of $310.94.

Lamb Weston (NYSE:LW) is now covered by Stephens. They set an "equal weight" rating and a $46.00 price target on the stock. This represents a 7.0% upside from the current price of $43.01.

Larimar Therapeutics (NASDAQ:LRMR) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $9.00 price target on the stock. This represents a 153.9% upside from the current price of $3.55.

Leidos (NYSE:LDOS) is now covered by BNP Paribas Exane. They set an "outperform" rating and a $165.00 price target on the stock. This represents a 25.1% upside from the current price of $131.94.

MaxLinear (NASDAQ:MXL) is now covered by Benchmark Co.. They set a "buy" rating and a $125.00 price target on the stock. This represents a 25.4% upside from the current price of $99.70.

Red Cat (NASDAQ:RCAT) is now covered by HC Wainwright. They set a "buy" rating and a $20.00 price target on the stock. This represents a 90.2% upside from the current price of $10.52.

Science Applications International (NASDAQ:SAIC) is now covered by BNP Paribas Exane. They set a "neutral" rating and a $95.00 price target on the stock. This represents a 5.5% downside from the current price of $100.56.

Sonic Automotive (NYSE:SAH) is now covered by UBS Group AG. They set a "buy" rating and a $90.00 price target on the stock. This represents a 8.7% upside from the current price of $82.83.

Vertex Pharmaceuticals (NASDAQ:VRTX) is now covered by Truist Financial Corporation. They set a "buy" rating and a $542.00 price target on the stock. This represents a 23.0% upside from the current price of $440.48.

Viking Therapeutics (NASDAQ:VKTX) is now covered by Truist Financial Corporation. They set a "buy" rating and a $83.00 price target on the stock. This represents a 160.4% upside from the current price of $31.88.

Workday (NASDAQ:WDAY) is now covered by Bank of America Corporation. They set a "neutral" rating and a $140.00 price target on the stock. This represents a 11.8% upside from the current price of $125.23.

View More New Coverage

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial